Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review (Q38989544)

8 September 2017

1 reference

title

Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review (English)

1 reference

8 September 2017

Erik Roj Larsen

2

0 references

author name string

Subethini Roopan

series ordinal

1

1 reference

8 September 2017

25 October 2016

1 reference

8 September 2017

Acta Neuropsychiatrica

1 reference

8 September 2017

29

1 reference

8 September 2017

127-139

1 reference

8 September 2017

3

1 reference

The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study.

8 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Hypercortisolemic depression is associated with increased intra-abdominal fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Influence of antidepressants on glycaemic control in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Treatment of depression in diabetes: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Diabetes with comorbid depression: role of SSRI in better glycemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Type of antidepressant therapy and risk of type 2 diabetes in people with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Comparison of antinociceptive and antidiabetic effects of sertraline and amitriptyline on streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Depression and diabetes: treatment and health-care delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

Improved insulin sensitivity in 80 nondiabetic patients with MDD after clinical remission in a double-blind, randomized trial of amitriptyline and paroxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Relationship between glycated haemoglobin levels and mean glucose levels over time

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes

1 reference

https://api.crossref.org/works/10.1017%2FNEU.2016.54

7 January 2021

Identifiers

DOI

10.1017/NEU.2016.54

1 reference

8 September 2017

1 reference

PubMed ID

27776567